Anti-Tumor Necrosis Factor Treatment in the Management of Pediatric Noninfectious Uveitis: Infliximab Versus Adalimumab


Ucan Gunduz G., Yalcinbayir Ö., Cekic Ş., Yildiz M., Kilic S. Ş.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, vol.37, no.4, pp.236-240, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 37 Issue: 4
  • Publication Date: 2021
  • Doi Number: 10.1089/jop.2020.0081
  • Journal Name: JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, CAB Abstracts, Chemical Abstracts Core, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.236-240
  • Keywords: adalimumab, infliximab, noninfectious, pediatric, uveitis
  • Bursa Uludag University Affiliated: Yes

Abstract

Purpose: Management of uveitis displays a particular challenge in childhood. This study aims to compare the efficacy and safety of infliximab (IFX) and adalimumab (ADA) in pediatric noninfectious uveitis that were refractory to conventional immunosuppresives.